SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹-2,731 Cr | ₹-1,998 Cr | ₹-1,316 Cr | ₹-1,515 Cr | ₹246 Cr |
What is the latest Total Non-Current Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹-2,731 Cr |
Mar2023 | ₹-1,998 Cr |
Mar2022 | ₹-1,316 Cr |
Mar2021 | ₹-1,515 Cr |
Mar2020 | ₹246 Cr |
How is Total Non-Current Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-2,731 Cr | Negative | |
Mar2023 | ₹-1,998 Cr | Negative | |
Mar2022 | ₹-1,316 Cr | Negative | |
Mar2021 | ₹-1,515 Cr | Negative | |
Mar2020 | ₹246 Cr | - |
Compare Total Non-Current Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹406,117.5 Cr | 0.2% | 1% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,844.0 Cr | 6.8% | 1.6% | 53.3% | Stock Analytics | |
CIPLA | ₹120,860.0 Cr | 4.4% | 2.9% | 4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,020.0 Cr | -0.7% | 4% | 25.1% | Stock Analytics | |
MANKIND PHARMA | ₹104,071.0 Cr | 7.6% | 16.3% | 2.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,755.1 Cr | 4.6% | 4.9% | -6.2% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | 0.2% |
1% |
6.3% |
SENSEX | 5.3% |
4% |
3.2% |
You may also like the below Video Courses